Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Prepaid Assets (2019 - 2025)

Fulcrum Therapeutics (FULC) has disclosed Prepaid Assets for 7 consecutive years, with $5.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 23.98% to $5.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.2 million, a 23.98% decrease, with the full-year FY2025 number at $5.2 million, down 23.98% from a year prior.
  • Prepaid Assets was $5.2 million for Q4 2025 at Fulcrum Therapeutics, down from $5.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $6.8 million in Q4 2024 to a low of $38000.0 in Q3 2021.
  • A 5-year average of $4.2 million and a median of $4.7 million in 2023 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: crashed 99.15% in 2021, then surged 13413.16% in 2022.
  • Fulcrum Therapeutics' Prepaid Assets stood at $38000.0 in 2021, then surged by 11397.37% to $4.4 million in 2022, then grew by 10.3% to $4.8 million in 2023, then surged by 41.23% to $6.8 million in 2024, then decreased by 23.98% to $5.2 million in 2025.
  • Per Business Quant, the three most recent readings for FULC's Prepaid Assets are $5.2 million (Q4 2025), $5.2 million (Q3 2025), and $5.0 million (Q1 2025).